Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load

Nutrition

Volumn 20, Issue 10, 2004, Pages 905-910

  Sir Petermann, Teresa ^a   Angel, Barbara ^a   Maliqueo, Manuel ^a   Santos, José Luis ^a   Riesco, María Virginia ^a   Toloza, Henry ^a   Pérez Bravo, Francisco ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

insulin receptor substrate 1; insulin secretion; polycystic ovary syndrome

Indexed keywords

ARGININE; CARBOHYDRATE; FRUCTOSE; GLUCOSE; GLYCINE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1;

ADOLESCENT; ADULT; ARTICLE; CARBOHYDRATE INTAKE; CHILE; CODON; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE DETERMINATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MODEL; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; AREA UNDER CURVE; ARGININE; BLOOD GLUCOSE; CHILE; CODON; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; GLYCINE; HUMANS; INSULIN; INSULIN RESISTANCE; PHOSPHOPROTEINS; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 4944267131     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2004.08.017     Document Type: Article

References (37)

1. Adams J., Polson D.W., Franks S. Prevalence of polycystic ovary syndrome in women with anovulation and idiopathic hirsutism. Br Med J. 293:1986;355
2. Hull M.G. Epidemiology of infertility and polycystic ovarian disease endocrinological and demographic studies. Gynecol Endocrinol. 1:1987;235
3. Zawadzki J.K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Dunaif A., Givens J., Haseltine F., Merrian G. Current issue in endocrinology and metabolism: polycystic ovary syndrome. 1992;377 Blackwell, New York
4. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:1995;322
5. Franks S. Polycystic ovary syndrome. N Engl J Med. 333:1995;853
6. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States a prospective study. J Clin Endocrinol Metab. 83:1998;3078
7. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab. 10:1996;221
8. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:1987;499
9. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165
10. Dunaif A. Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis. Endocr Rev. 18:1997;774
11. Legro R.S., Kunselman A.R., Dodson W.C., Dunaif A. Prevalence and predictors of risk for type II diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 84:1999;165
12. O'Meara N.M., Blackman J.D., Ehrmann D.A., et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1993;1241
13. Ehrmann D.A., Sturis J., Byrne M.M., Karrison T., Rosenfield R.L., Polonsky K.S. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 96:1995;520
14. Backer J.M., Myers M.G. Jr, Shoelson S.E., et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:1992;3469
15. Myers M.G. Jr, Sun X.J., White M.F. The IRS-1 signaling system. Trends Biochem Sci. 19:1994;289
16. Waters S.B., Yamauchi K., Pessin J.E. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J Biol Chem. 268:1993;22231
17. Araki E., Lipes M.A., Patti M.E., et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:1994;186
18. Tamemoto H., Kadowaki T., Tobe K., et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:1994;182
19. Kulkarni R.N., Winnay J.N., Daniels M., et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest. 104:1999;R69
20. Imai Y., Fusco A., Suzuki Y., Lesniak M.A., et al. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 79:1994;1655
21. Hitman G.A., Hawrami K., McCarthy M.I., et al. Insulin receptor substrate-1 gene mutation in NIDDM implications for the study of polygenic disease. Diabetologia. 38:1995;481
22. Almind K., Inoue G., Pedersen O., Kahn C.R. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest. 97:1996;2569
23. Hribal M.L., Federici M., Porzio O., et al. The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab. 85:2000;2004
24. Porzio O., Federici M., Hribal M.L., et al. The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest. 104:1999;357
25. Clausen J.O., Hansen T., Bjorbaek C., et al. Insulin resistance interactions between obesity and a common variant of insulin receptor substrate-1. Lancet. 346:1995;397
26. Stumvoll M., Fritsche A., Volk A., et al. The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes. 50:2001;882
27. El Mkadem S.A., Lautier C., Macari F., et al. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes. 50:2001;2164
28. Sir-Petermann T., Perez-Bravo F., Angel B., Maliqueo M., Calvillan M., Palomino A. G972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia. 44:2001;1200
29. Carmina E., Lobo R.A. Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 84:1999;1897
30. World Health Organisation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation, part I diagnosis and classification of diabetes mellitus. 1999;World Health Organisation, Geneva
31. Sir-Petermann T., Recabarren S.E., Bittl A., Jager W., Zimmermann U., Wildt L. A simple device for serial blood collection in human subjects and animals. Exp Clin Endocrinol. 138:1995;398
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412
33. Matsumoto K., Miyake S., Yano M., et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care. 20:1997;1562
34. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing comparison with the euglycemic insulin clamp. Diabetes Care. 22:1999;1462
35. Baroni M.G., Arca M., Sentinelli F., et al. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia. 44:2001;367
36. Ehrmann D.A., Tang X., Yoshiuchi I., Cox N.J., Bell G.I. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab. 87:2002;4297
37. Almind K., Bjorbaek C., Vestergaard H., Hansen T., Echwald S., Pedersen O. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 342:1993;1430